Trial Profile
Study to evaluate efficacy of paliperidone ER in negative symptoms, after switching from a regimen of risperdal or atypical antipsychotics, in schizophrenia patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Feb 2015
Price :
$35
*
At a glance
- Drugs Paliperidone (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 02 Feb 2015 New trial record